Medplus Health Services (Mid Cap) Share Target 2024, 2025 To 2039
|
MedPlus Health Services Limited |
|||
|
Price: ₹848.05 | ||
| 52 Week Low: ₹598.60 52 Week High: ₹875.65 |
|||
| Market Capital: 8,412.54 Crore (Midcap) | |||
| Healthcare -> Pharmaceutical Retailers | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Medplus Health Services Share Price Target For 2024
- 1.1.1: Medplus Health Services Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Medplus Health Services Share Price Target For 2025
- 1.2.1: Medplus Health Services Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Medplus Health Services Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Medplus Health Services Brief Company Overview
- 4: Medplus Health Services Financial Performance
- 4.0.1: Is Medplus Health Services A Good Buy For Long Term?
To predict the Medplus Health Services's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Medplus Health Services Share Price Target For 2024
The line chart displays the monthly closing prices of Medplus Health Services with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Medplus Health Services shares in 2024, see the table below.
Medplus Health Services Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 895.2 (+5.55%) | Fibonacci Extension Level 50.00% |
| 2024 Target 2 | 871.0 (+2.70%) | Price Action: 10 Dec 2024 High |
| 2024 Target 1 | 862.0 (+1.64%) | Price Action: 17 Dec 2024 High |
| Current Price | 848.05 | Medplus Health Services's share price as of 20 Dec 2024 |
| Stop Loss 1 | 839.0 (-1.07%) | Price Action: Sep 2023 High |
| Stop Loss 2 | 828.5 (-2.31%) | Price Action: 09 Dec 2024 Low |
| Stop Loss 3 | 807.75 (-4.76%) | Price Action: 04 Dec 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Medplus Health Services is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹806.18 serves as the nearest technical reference point.
Historical Returns: 3-month: +26.43% | 6-month: +24.27% | 1-year: +12.96%
Medplus Health Services Share Price Target For 2025
The line chart displays the monthly closing prices of Medplus Health Services with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Medplus Health Services shares in 2025, see the table below.
Medplus Health Services Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1045.3 (+23.25%) | Price Action: Chart |
| 2025 Target 2 | 1025.81 (+20.96%) | Fibonacci Extension Level 64.90% |
| 2025 Target 1 | 1014.18 (+19.58%) | Fibonacci Extension Level 150.00% |
| Current Price | 848.05 | Medplus Health Services's share price as of 20 Dec 2024 |
| Stop Loss 1 | 804.5 (-5.14%) | Price Action: Aug 2023 Low |
| Stop Loss 2 | 793.0 (-6.50%) | Price Action: Mar 2023 High |
| Stop Loss 3 | 785.0 (-7.44%) | Price Action: Aug 2022 High |
Long-Term Technical Outlook
52-Week Range Analysis: Medplus Health Services is currently trading near its 52-week high of ₹875.65, showing strong yearly momentum.
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +12.96% | 3-year: NA | 5-year: NA
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Medplus Health Services Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹848.05 | ||
| 2024 | ₹658.46 | -22.36% | ₹668.34 |
| 2025 | ₹628.21 | -4.59% | ₹658.26 |
| 2026 | ₹559.29 | -10.97% | ₹605.75 |
| 2027 | ₹492.56 | -11.93% | ₹555.33 |
| 2028 | ₹607.08 | +23.25% | ₹627.95 |
| 2029 | ₹594.67 | -2.04% | ₹611.69 |
| 2030 | ₹578.87 | -2.66% | ₹593.24 |
| 2031 | ₹560.83 | -3.12% | ₹584.53 |
| 2032 | ₹544.30 | -2.95% | ₹562.82 |
| 2033 | ₹522.14 | -4.07% | ₹546.89 |
| 2034 | ₹509.07 | -2.50% | ₹525.30 |
| 2035 | ₹493.07 | -3.14% | ₹507.64 |
| 2036 | ₹475.16 | -3.63% | ₹497.68 |
| 2037 | ₹493.09 | +3.77% | ₹500.49 |
| 2038 | ₹488.69 | -0.89% | ₹497.79 |
| 2039 | ₹508.59 | +4.07% | ₹516.22 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Medplus Health Services Brief Company Overview
MedPlus Health Services Limited: A Healthcare Retail Giant MedPlus Health Services, established in 2006, is a leading healthcare retailer in India, offering a comprehensive range of products and services. Key Products and Services: Retail of medicines and general...
items Manufacturing and trading of pharmaceuticals Wholesale cash and carry services Pathological laboratory testing Market Presence and Reputation: With a wide network of stores across India, MedPlus has established a strong presence in the retail healthcare market. The company is renowned for its commitment to quality and customer satisfaction, earning it a reputable position in the industry. Diverse Product Range: MedPlus offers a diverse product range, including medicines, vitamins, medical devices, fast-moving consumer goods, and more. This variety caters to the comprehensive healthcare needs of its customers. Commitment to Quality: MedPlus is dedicated to providing quality healthcare products and services. The company adheres to strict quality standards and ensures that all its products meet the highest safety and efficacy guidelines.Medplus Health Services Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 8,412.54 Crore | Market valuation of Medplus Health Services's shares. |
| Revenue (TTM) | 5,829.38 Crore | Total revenue generated by Medplus Health Services over the past twelve months. |
| Net Income (TTM) | +760,499,968.00 | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +2.26% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +1.30% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+15.90% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+279.39% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
64 | Company's total debt divided by total shareholder equity. |
| Total Debt | 1,009.56 Crore | Sum of Medplus Health Services's current & long-term financial obligations. |
| Total Cash | 174.23 Crore | Total amount of liquid funds available to Medplus Health Services. |
| Beta | 0.76 | Beta is less than 1 indicating that the Medplus Health Services's price is less volatile than the market. |
Is Medplus Health Services A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
